Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of thyroid cancer cells to therapeutic targeting of Akt and mammalian …

D Liu, P Hou, Z Liu, G Wu, M Xing - Cancer research, 2009 - AACR
We investigated the genotype-dependent therapeutic potential of targeting the
phosphoinositide 3-kinase (PI3K)/Akt pathway for thyroid cancer. Proliferation of TPC1 …
被引用次数：118 相关文章

Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of thyroid cancer cells to therapeutic targeting of Akt and mammalian …

D Liu, P Hou, Z Liu, G Wu, MM Xing - Cancer Research, 2009 - pure.johnshopkins.edu
We investigated the genotype-dependent therapeutic potential of targeting the
phosphoinositide 3-kinase (PI3K)/Akt pathway for thyroid cancer. Proliferation of TPC1 …

Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of thyroid cancer cells to therapeutic targeting of Akt and mammalian …

D Liu, P Hou, Z Liu, G Wu, M Xing - Cancer research, 2009 - pubmed.ncbi.nlm.nih.gov
We investigated the genotype-dependent therapeutic potential of targeting the
phosphoinositide 3-kinase (PI3K)/Akt pathway for thyroid cancer. Proliferation of TPC1 …

[引用][C] Genetic Alterations in the Phosphoinositide 3-Kinase/Akt Signaling Pathway Confer Sensitivity of Thyroid Cancer Cells to Therapeutic Targeting of Akt and …

D LIU, P HOU, ZHI LIU, G WU… - … research (Chicago, Ill.), 2009 - pascal-francis.inist.fr
Genetic Alterations in the Phosphoinositide 3-Kinase/Akt Signaling Pathway Confer
Sensitivity of Thyroid Cancer Cells to Therapeutic Targeting of Akt and Mammalian Target of …

Genetic Alterations in the Phosphoinositide 3-Kinase/Akt Signaling Pathway Confer Sensitivity of Thyroid Cancer Cells to Therapeutic Targeting of Akt and Mammalian …

D Liu, P Hou, Z Liu, G Wu, M Xing - Cancer Research, 2009 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> We investigated the genotype-dependent
therapeutic potential of targeting the phosphoinositide 3-kinase (PI3K)/Akt pathway for …

Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of thyroid cancer cells to therapeutic targeting of Akt and mammalian …

D Liu, P Hou, Z Liu, G Wu, M Xing - Cancer Research, 2009 - hero.epa.gov
We investigated the genotype-dependent therapeutic potential of targeting the
phosphoinositide 3-kinase (PI3K)/Akt pathway for thyroid cancer. Proliferation of TPC1 …

Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of thyroid cancer cells to therapeutic targeting of Akt and mammalian …

D Liu, P Hou, Z Liu, G Wu, M Xing - Cancer Research, 2009 - europepmc.org
We investigated the genotype-dependent therapeutic potential of targeting the PI3K/Akt
pathway for thyroid cancer. Proliferation of TPC1, Hth7, FTC133, OCUT1, K1, and BCPAP …

[引用][C] Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of thyroid cancer cells to therapeutic targeting of Akt and …

D LIU - Cancer Res, 2009 - cir.nii.ac.jp
Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of
thyroid cancer cells to therapeutic targeting of Akt and mammalian target of rapamycin | CiNii …

[引用][C] Genetic Alterations in the Phosphoinositide 3-Kinase/Akt Signaling Pathway Confer Sensitivity of Thyroid Cancer Cells to Therapeutic Targeting of Akt and …

D LIU, P HOU, ZHI LIU, G WU… - Cancer …, 2009 - American Association for Cancer …